Posted: Tuesday, October 28, 2025
CancerCare
Update Carfilzomib Kyprolis
(UPDATE) Daratumumab
CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
(UPDATE) Ixazomib
Selinexor